Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Targeted gene evolution in Escherichia coli using a highly error-prone DNA polymerase I.

Authors: Camps, Manel; Naukkarinen, Jussi; Johnson, Ben P; Loeb, Lawrence A

Published In Proc Natl Acad Sci U S A, (2003 Aug 19)

Abstract: We present a system for random mutagenesis in Escherichia coli for the evolution of targeted genes. To increase error rates of DNA polymerase I (Pol I) replication, we introduced point mutations in three structural domains that govern Pol I fidelity. Expression of error-prone Pol I in vivo results in strong mutagenesis of a target sequence encoded in a Pol I-dependent plasmid (8.1 x 10-4 mutations per bp, an 80,000-fold increase), with a preference for plasmid relative to chromosome sequence. Mutagenesis is maximal in cultures maintained at stationary phase. Mutations are evenly distributed and show a variety of base pair substitutions, predominantly transitions. Mutagenesis extends at least 3 kb beyond the 400-500 nt reportedly synthesized by Pol I. We demonstrate that our error-prone Pol I can be used to generate enzymes with distinct properties by generating TEM-1 beta-lactamase mutants able to hydrolyze a third-generation lactam antibiotic, aztreonam. Three different mutations contribute to aztreonam resistance. Two are found in the extended-spectrum beta-lactamases most frequently identified in clinical isolates, and the third (G276R) has not been previously described. Our system of targeted mutagenesis in E. coli should have an impact on enzyme-based applications in areas such as synthetic chemistry, gene therapy, and molecular biology. Given the structural conservation between polymerases, this work should also provide a reference for altering the fidelity of other polymerases.

PubMed ID: 12909725 Exiting the NIEHS site

MeSH Terms: Anti-Bacterial Agents/pharmacology; Aztreonam/pharmacology; Base Sequence; DNA Polymerase I/genetics*; DNA Polymerase I/metabolism; DNA, Bacterial/genetics; Directed Molecular Evolution*; Drug Resistance, Bacterial/genetics; Escherichia coli/drug effects; Escherichia coli/enzymology*; Escherichia coli/genetics*; Genes, Bacterial; Genes, Reporter; Genetic Engineering; Mutagenesis, Site-Directed; Phenotype; Plasmids/genetics; Protein Engineering; beta-Lactamases/genetics

to Top